Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals
Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may
Read more
Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may
Read moreSince the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Read moreSepsis is brought on by infection with a pathogen, to which the body responds excessively and perpetuates a systemic immune
Read moreInfluenza and pneumonia vaccinations are associated with fewer hospital deaths in patients with heart failure. That’s the result of a
Read moreAcute Respiratory Distress Syndrome (ARDS), when caused by a bacterial toxin known as Staphylococcal enterotoxin, can be completely prevented by
Read more